A comparison of the effectiveness of dexmedetomidine versus propofol target-controlled infusion for sedation during fibreoptic nasotracheal intubation

Anaesthesia
C-J TsaiI-C Lu

Abstract

Fibreoptic intubation is a valuable modality for airway management. This study aimed to compare the effectiveness of dexmedetomidine vs target controlled propofol infusion in providing sedation during fibreoptic intubation. Forty patients with anticipated difficult airways and due to undergo tracheal intubation for elective surgery were enrolled and randomly allocated into the dexmedetomidine group (1.0 microg.kg(-1) over 10 min) (n = 20) or the propofol target controlled infusion group (n = 20). Intubating conditions and patient tolerance as graded by a scoring system were evaluated as primary outcomes. Intubation was successful in all patients. Satisfactory intubating conditions were found in both groups (19/20 in each group). The median (IOR [range]) comfort score was 2 (1-2 [1-4]) in the dexmedetomidine group and 3 (2-4 [2-5]) in the propofol group (p = 0.027), favouring the former. The dexmedetomidine group experienced fewer airway events and less heart rate response to intubation than the propofol group (p < 0.003 and p = 0.007, respectively). Both dexmedetomidine and propofol target-controlled infusion are effective for fibreoptic intubation. Dexmedetomidine allows better tolerance, more stable haemodynamic status and pr...Continue Reading

References

Mar 7, 2000·Anesthesia and Analgesia·J E HallT J Ebert
Oct 25, 2000·Anesthesiology·T Kamibayashi, M Maze
Apr 16, 2002·Acta Anaesthesiologica Scandinavica·W PuchnerH Gombotz
Jul 30, 2003·European Journal of Anaesthesiology·E KnolleH G Kress
Aug 17, 2005·Canadian Journal of Anaesthesia = Journal Canadien D'anesthésie·M MaroofMoin Ashraf
Sep 30, 2005·Anesthesia and Analgesia·Edmund H JoosteLena S Sun
Oct 28, 2006·Acta Anaesthesiologica Scandinavica·D M Stamenkovic, M Hassid
Mar 24, 2007·Journal of Clinical Anesthesia·Sergio D BergeseMark A Gerhardt
Sep 18, 2007·Journal of Clinical Anesthesia·Basem AbdelmalakD John Doyle

❮ Previous
Next ❯

Citations

Mar 21, 2013·Canadian Journal of Anaesthesia = Journal Canadien D'anesthésie·Kevin D Johnston, Mridula R Rai
Feb 28, 2014·Journal of Anaesthesiology, Clinical Pharmacology·Suvadeep SenDalim Kumar Baidya
Sep 5, 2014·Journal of Medical Case Reports·Zhi-Bin ZhouXia Feng
Jul 8, 2014·Acta Anaesthesiologica Taiwanica : Official Journal of the Taiwan Society of Anesthesiologists·I-Cheng LuKuang-I Cheng
Oct 13, 2011·Veterinary Anaesthesia and Analgesia·Bruno H PypendopJan E Ilkiw
Apr 28, 2011·Journal of Veterinary Pharmacology and Therapeutics·A EscobarJ E Ilkiw
Oct 18, 2016·Anesthesia, Essays and Researches·Radhe SharanAnju Bala
Jul 22, 2015·American Journal of Therapeutics·Luo-Jing ZhouLi-Jian Tao
Feb 26, 2016·Pain Practice : the Official Journal of World Institute of Pain·Feline F J A Ter BruggenFrank J P M Huygen
Nov 20, 2016·Pain Practice : the Official Journal of World Institute of Pain·Feline F J A Ter BruggenFrank J P M Huygen
Jan 21, 2014·The Cochrane Database of Systematic Reviews·Xing-Ying HeXue-Yin Shi
Dec 5, 2019·National Journal of Maxillofacial Surgery·Arun KumarGyan Prakash Singh
Mar 25, 2017·The Journal of Pediatric Pharmacology and Therapeutics : JPPT : the Official Journal of PPAG·Natalie BehrleAbdallah Dalabih
Jan 22, 2021·The Journal of International Medical Research·Yuanyuan MaShengjin Ge
Dec 29, 2020·Technology in Cancer Research & Treatment·Lihong ZhengXiaoting Wang

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.